{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:09:56Z","timestamp":1790838596162,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["Y20240829"],"award-info":[{"award-number":["Y20240829"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijpx.2025.100404","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:52:02Z","timestamp":1758617522000},"page":"100404","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Cell membrane-camouflaged nanomedicines for enhanced thrombolysis and blood-brain barrier penetration in ischemic stroke therapy"],"prefix":"10.1016","volume":"10","author":[{"given":"Xiachan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengrui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjie","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijpx.2025.100404_bb0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11910-023-01266-2","article-title":"Contemporary antiplatelet and anticoagulant therapies for secondary stroke prevention: a narrative review of current literature and guidelines","volume":"23","author":"Bhatia","year":"2023","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100404_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-019-0118-8","article-title":"Ischaemic stroke","volume":"5","author":"Campbell","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ijpx.2025.100404_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2020.05.028","article-title":"Hybrid cell membrane-coated nanoparticles: a multifunctional biomimetic platform for cancer diagnosis and therapy","volume":"112","author":"Chen","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpx.2025.100404_bb0020","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jconrel.2021.10.020","article-title":"Nanomedicines, an emerging therapeutic regimen for treatment of ischemic cerebral stroke: a review","volume":"340","author":"Chen","year":"2021","journal-title":"J. Control. Release"},{"issue":"17","key":"10.1016\/j.ijpx.2025.100404_bb0025","doi-asserted-by":"crossref","first-page":"e2207787","DOI":"10.1002\/adma.202207787","article-title":"Living leukocyte-based drug delivery systems","volume":"35","author":"Chen","year":"2023","journal-title":"Adv. Mater."},{"issue":"22","key":"10.1016\/j.ijpx.2025.100404_bb0030","doi-asserted-by":"crossref","first-page":"e1706245","DOI":"10.1002\/adma.201706245","article-title":"Neutrophil-based drug delivery systems","volume":"30","author":"Chu","year":"2018","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100404_bb0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/CH-2010-1253","article-title":"An overview about erythrocyte membrane","volume":"44","author":"de Oliveira","year":"2010","journal-title":"Clin. Hemorheol. Microcirc."},{"issue":"2","key":"10.1016\/j.ijpx.2025.100404_bb0040","first-page":"1272","article-title":"Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke","volume":"13","author":"Dong","year":"2019","journal-title":"ACS Nano"},{"issue":"20","key":"10.1016\/j.ijpx.2025.100404_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207600","article-title":"Nanomedicine for ischemic stroke","volume":"21","author":"Dong","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ijpx.2025.100404_bb0050","doi-asserted-by":"crossref","first-page":"2309167","DOI":"10.1002\/adfm.202309167","article-title":"A homing peptide modified neutrophil membrane biomimetic nanoparticles in response to ROS\/inflammatory microenvironment for precise targeting treatment of ischemic stroke","volume":"34","author":"Dong","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ijpx.2025.100404_bb0055","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jconrel.2024.06.017","article-title":"Precisely targeted drug delivery by mesenchymal stem cells-based biomimetic liposomes to cerebral ischemia-reperfusion injured hemisphere","volume":"371","author":"Dong","year":"2024","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijpx.2025.100404_bb0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/s12951-022-01602-7","article-title":"An ischemia-homing bioengineered nano-scavenger for specifically alleviating multiple pathogeneses in ischemic stroke","volume":"20","author":"Duan","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.ijpx.2025.100404_bb0065","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1021\/acsnano.0c07973","article-title":"Neutrophil-like cell-membrane-coated nanozyme therapy for ischemic brain damage and long-term neurological functional recovery","volume":"15","author":"Feng","year":"2021","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.ijpx.2025.100404_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105796","article-title":"The development of novel drug treatments for stroke patients: a review","volume":"23","author":"Frank","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"46","key":"10.1016\/j.ijpx.2025.100404_bb0075","doi-asserted-by":"crossref","first-page":"1801362","DOI":"10.1002\/adma.201801362","article-title":"Overcoming the blood-brain barrier: the role of nanomaterials in treating neurological diseases","volume":"30","author":"Furtado","year":"2018","journal-title":"Adv. Mater."},{"issue":"10","key":"10.1016\/j.ijpx.2025.100404_bb0080","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"20","year":"2021","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.ijpx.2025.100404_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121836","article-title":"Cancer cell membrane-coated nanoparticles for cancer management","volume":"11","author":"Harris","year":"2019","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.ijpx.2025.100404_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054334","article-title":"Neuroprotective strategies for ischemic stroke-future perspectives","volume":"24","author":"Haupt","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2025.100404_bb0095","doi-asserted-by":"crossref","first-page":"121111","DOI":"10.1016\/j.biomaterials.2021.121111","article-title":"Nanoparticles-mediated emerging approaches for effective treatment of ischemic stroke","volume":"277","author":"He","year":"2021","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.ijpx.2025.100404_bb0100","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1021\/acs.nanolett.1c00231","article-title":"Preferential targeting cerebral ischemic lesions with cancer cell-inspired nanovehicle for ischemic stroke treatment","volume":"21","author":"He","year":"2021","journal-title":"Nano Lett."},{"issue":"11","key":"10.1016\/j.ijpx.2025.100404_bb0105","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1097\/CCM.0000000000004597","article-title":"Management of acute ischemic stroke","volume":"48","author":"Herpich","year":"2020","journal-title":"Crit. Care Med."},{"issue":"7","key":"10.1016\/j.ijpx.2025.100404_bb0110","doi-asserted-by":"crossref","first-page":"eaau8301","DOI":"10.1126\/sciadv.aau8301","article-title":"Accessing neuroinflammation sites: monocyte\/neutrophil-mediated drug delivery for cerebral ischemia","volume":"5","author":"Hou","year":"2019","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.ijpx.2025.100404_bb0115","first-page":"2006","article-title":"Modulators of microglia activation and polarization in ischemic stroke","volume":"21","author":"Jiang","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.ijpx.2025.100404_bb0120","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.scib.2024.06.005","article-title":"CSF multi-omics of intracerebral hemorrhage from onset to reperfusion underscores lipid metabolism in functional outcome","volume":"70","author":"Jiang","year":"2025","journal-title":"Sci. Bull."},{"issue":"3","key":"10.1016\/j.ijpx.2025.100404_bb0125","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1161\/STROKEAHA.120.032810","article-title":"Thrombus composition and efficacy of thrombolysis and thrombectomy in acute ischemic stroke","volume":"52","author":"Jolugbo","year":"2021","journal-title":"Stroke"},{"issue":"20 Suppl 2","key":"10.1016\/j.ijpx.2025.100404_bb0130","first-page":"S68","article-title":"Thrombus composition, imaging, and outcome prediction in acute ischemic stroke","volume":"97","author":"Joundi","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ijpx.2025.100404_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010014","article-title":"Neuroinflammation in cerebral ischemia and ischemia\/reperfusion injuries: from pathophysiology to therapeutic strategies","volume":"23","author":"Jurcau","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ijpx.2025.100404_bb0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/1076029616660762","article-title":"Antiplatelet and anticoagulant therapies for prevention of ischemic stroke","volume":"23","author":"Kapil","year":"2017","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.ijpx.2025.100404_bb0145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2019.02.031","article-title":"Emerging paradigms in nanotechnology for imaging and treatment of cerebral ischemia","volume":"300","author":"Kaviarasi","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2025.100404_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1102463","article-title":"Tenecteplase vs. alteplase for treatment of acute ischemic stroke: a systematic review and meta-analysis of randomized trials","volume":"14","author":"Kobeissi","year":"2023","journal-title":"Front. Neurol."},{"issue":"52","key":"10.1016\/j.ijpx.2025.100404_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202209405","article-title":"Neuroprotective treatments for ischemic stroke: opportunities for nanotechnology","volume":"32","author":"Kong","year":"2022","journal-title":"Adv. Funct. Mater."},{"issue":"5","key":"10.1016\/j.ijpx.2025.100404_bb0160","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1021\/acsnano.3c08734","article-title":"An ultrasmall Cu\/Cu2O nanoparticle-based diselenide-bridged nanoplatform mediating reactive oxygen species scavenging and neuronal membrane enhancement for targeted therapy of ischemic stroke","volume":"18","author":"Kong","year":"2024","journal-title":"ACS Nano"},{"issue":"13","key":"10.1016\/j.ijpx.2025.100404_bb0165","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.1039\/C5NR07588B","article-title":"Monocyte cell membrane-derived nanoghosts for targeted cancer therapy","volume":"8","author":"Krishnamurthy","year":"2016","journal-title":"Nanoscale"},{"issue":"7","key":"10.1016\/j.ijpx.2025.100404_bb0170","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1634\/stemcells.2004-0342","article-title":"Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis","volume":"23","author":"Kucia","year":"2005","journal-title":"Stem Cells"},{"key":"10.1016\/j.ijpx.2025.100404_bb0175","doi-asserted-by":"crossref","first-page":"120395","DOI":"10.1016\/j.ijpharm.2021.120395","article-title":"Platelet membrane camouflaged nanoparticles: biomimetic architecture for targeted therapy","volume":"598","author":"Kunde","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ijpx.2025.100404_bb0180","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3892\/ijmm.2015.2344","article-title":"Effect of SDF-1\/CXCR4 axis on the migration of transplanted bone mesenchymal stem cells mobilized by erythropoietin toward lesion sites following spinal cord injury","volume":"36","author":"Li","year":"2015","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.ijpx.2025.100404_bb0185","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1021\/acsnano.9b08587","article-title":"Platelet membrane biomimetic magnetic nanocarriers for targeted delivery and in situ generation of nitric oxide in early ischemic stroke","volume":"14","author":"Li","year":"2020","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.ijpx.2025.100404_bb0190","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.apsb.2020.11.019","article-title":"Recent advances in nanomedicines for the treatment of ischemic stroke","volume":"11","author":"Li","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"20","key":"10.1016\/j.ijpx.2025.100404_bb0195","doi-asserted-by":"crossref","first-page":"e2101526","DOI":"10.1002\/advs.202101526","article-title":"Macrophage-disguised manganese dioxide nanoparticles for neuroprotection by reducing oxidative stress and modulating inflammatory microenvironment in acute ischemic stroke","volume":"8","author":"Li","year":"2021","journal-title":"Adv. Sci."},{"issue":"10","key":"10.1016\/j.ijpx.2025.100404_bb0200","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1002\/anie.202010391","article-title":"Ultrasound controlled anti-inflammatory polarization of platelet decorated microglia for targeted ischemic stroke therapy","volume":"60","author":"Li","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"issue":"9","key":"10.1016\/j.ijpx.2025.100404_bb0205","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2217\/nnm-2023-0266","article-title":"Advances in nanomedicines: a promising therapeutic strategy for ischemic cerebral stroke treatment","volume":"19","author":"Li","year":"2024","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijpx.2025.100404_bb0210","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jconrel.2023.05.009","article-title":"Recent advances in biomimetic nanodelivery systems: new brain-targeting strategies","volume":"358","author":"Liao","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2025.100404_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.885190","article-title":"Recent advances in nanomaterials for diagnosis, treatments, and neurorestoration in ischemic stroke","volume":"16","author":"Lin","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ijpx.2025.100404_bb0220","doi-asserted-by":"crossref","first-page":"213379","DOI":"10.1016\/j.bioadv.2023.213379","article-title":"Biomimetic oxygen-boosted hybrid membrane nanovesicles as the treatment strategy for ischemic stroke with the concept of the neurovascular unit","volume":"148","author":"Liu","year":"2023","journal-title":"Biomater. Adv."},{"issue":"5","key":"10.1016\/j.ijpx.2025.100404_bb0225","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.3390\/ijms25052927","article-title":"The optimization design of macrophage membrane camouflaging liposomes for alleviating ischemic stroke injury through intranasal delivery","volume":"25","author":"Liu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpx.2025.100404_bb0230","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.2147\/IJN.S458656","article-title":"Targeted delivery of macrophage membrane biomimetic liposomes through intranasal administration for treatment of ischemic stroke","volume":"19","author":"Liu","year":"2024","journal-title":"Int. J. Nanomedicine"},{"issue":"8","key":"10.1016\/j.ijpx.2025.100404_bb0235","doi-asserted-by":"crossref","first-page":"e2200289","DOI":"10.1002\/smtd.202200289","article-title":"Macrophage cell membrane-cloaked nanoplatforms for biomedical applications","volume":"6","author":"Lopes","year":"2022","journal-title":"Small Methods"},{"issue":"6","key":"10.1016\/j.ijpx.2025.100404_bb0240","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1021\/acsnano.8b00477","article-title":"Bioengineered boronic ester modified dextran polymer nanoparticles as reactive oxygen species responsive nanocarrier for ischemic stroke treatment","volume":"12","author":"Lv","year":"2018","journal-title":"ACS Nano"},{"issue":"35","key":"10.1016\/j.ijpx.2025.100404_bb0245","doi-asserted-by":"crossref","first-page":"e1902011","DOI":"10.1002\/smll.201902011","article-title":"Targeted drug delivery to stroke via chemotactic recruitment of nanoparticles coated with membrane of engineered neural stem cells","volume":"15","author":"Ma","year":"2019","journal-title":"Small"},{"issue":"29","key":"10.1016\/j.ijpx.2025.100404_bb0250","doi-asserted-by":"crossref","first-page":"e2401462","DOI":"10.1002\/adhm.202401462","article-title":"Phosphorus dendrimers co-deliver fibronectin and edaravone for combined ischemic stroke treatment via cooperative modulation of microglia\/neurons and vascular regeneration","volume":"13","author":"Ma","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"4","key":"10.1016\/j.ijpx.2025.100404_bb0255","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/STROKEAHA.119.027921","article-title":"Trends of r-tPA (recombinant tissue-type plasminogen activator) treatment and treatment-influencing factors in acute ischemic stroke","volume":"51","author":"Marko","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.ijpx.2025.100404_bb0260","doi-asserted-by":"crossref","first-page":"121814","DOI":"10.1016\/j.lfs.2023.121814","article-title":"Molecular mechanisms of ischemia and glutamate excitotoxicity","volume":"328","author":"Neves","year":"2023","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.ijpx.2025.100404_bb0265","doi-asserted-by":"crossref","first-page":"e2006484","DOI":"10.1002\/smll.202006484","article-title":"Immune cell membrane-coated biomimetic nanoparticles for targeted cancer therapy","volume":"17","author":"Oroojalian","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.ijpx.2025.100404_bb0270","doi-asserted-by":"crossref","first-page":"113518","DOI":"10.1016\/j.expneurol.2020.113518","article-title":"Emerging neuroprotective strategies for the treatment of ischemic stroke: an overview of clinical and preclinical studies","volume":"335","author":"Paul","year":"2021","journal-title":"Exp. Neurol."},{"issue":"12","key":"10.1016\/j.ijpx.2025.100404_bb0275","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.ijpx.2025.100404_bb0280","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s12264-019-00388-3","article-title":"Dual functions of microglia in ischemic stroke","volume":"35","author":"Qin","year":"2019","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.ijpx.2025.100404_bb0285","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.actbio.2022.10.022","article-title":"Mesenchymal stem cell-derived extracellular vesicles attenuate tPA-induced blood\u2013brain barrier disruption in murine ischemic stroke models","volume":"154","author":"Qiu","year":"2022","journal-title":"Acta Biomater."},{"issue":"16","key":"10.1016\/j.ijpx.2025.100404_bb0290","doi-asserted-by":"crossref","first-page":"e2200416","DOI":"10.1002\/adhm.202200416","article-title":"Annexin V-modified platelet-biomimetic nanomedicine for targeted therapy of acute ischemic stroke","volume":"11","author":"Quan","year":"2022","journal-title":"Adv. Healthc. Mater."},{"issue":"4","key":"10.1016\/j.ijpx.2025.100404_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12040812","article-title":"Molecular mechanisms of ischemic stroke: a review integrating clinical imaging and therapeutic perspectives","volume":"12","author":"Rehman","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijpx.2025.100404_bb0300","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2024.07.013","article-title":"From bench to bedside: platelet biomimetic nanoparticles as a promising carriers for personalized drug delivery","volume":"373","author":"Safdar","year":"2024","journal-title":"J. Control. Release"},{"issue":"20 Suppl 2","key":"10.1016\/j.ijpx.2025.100404_bb0305","first-page":"S6","article-title":"Global epidemiology of stroke and access to acute ischemic stroke interventions","volume":"97","author":"Saini","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.ijpx.2025.100404_bb0310","doi-asserted-by":"crossref","first-page":"105458","DOI":"10.1016\/j.neuint.2022.105458","article-title":"Stroke: molecular mechanisms and therapies: update on recent developments","volume":"162","author":"Shehjar","year":"2023","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100404_bb0315","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1021\/acs.nanolett.9b04974","article-title":"Bioinspired nanosponge for salvaging ischemic stroke via free radical scavenging and self-adapted oxygen regulating","volume":"20","author":"Shi","year":"2020","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100404_bb0320","doi-asserted-by":"crossref","first-page":"2101158","DOI":"10.1002\/smtd.202101158","article-title":"Engineering CXCL12 biomimetic decoy-integrated versatile immunosuppressive nanoparticle for ischemic stroke therapy with management of overactivated brain immune microenvironment","volume":"6","author":"Shi","year":"2021","journal-title":"Small Methods"},{"issue":"32","key":"10.1016\/j.ijpx.2025.100404_bb0325","doi-asserted-by":"crossref","first-page":"2315275","DOI":"10.1002\/adfm.202315275","article-title":"Neutrophil hitchhiking biomimetic nanozymes prime neuroprotective effects of ischemic stroke in a tailored \u201cburning the bridges\u201d manner","volume":"34","author":"Song","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"9","key":"10.1016\/j.ijpx.2025.100404_bb0330","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1182\/blood-2008-04-144758","article-title":"Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment","volume":"112","author":"Stoll","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ijpx.2025.100404_bb0335","doi-asserted-by":"crossref","first-page":"100674","DOI":"10.1016\/j.mtbio.2023.100674","article-title":"Neutrophil membrane fusogenic nanoliposomal leonurine for targeted ischemic stroke therapy via remodeling cerebral niche and restoring blood-brain barrier integrity","volume":"20","author":"Tang","year":"2023","journal-title":"Mater Today Bio."},{"issue":"21","key":"10.1016\/j.ijpx.2025.100404_bb0340","doi-asserted-by":"crossref","first-page":"2312897","DOI":"10.1002\/adma.202312897","article-title":"Blood-brain barrier-penetrating and lesion-targeting nanoplatforms inspired by the pathophysiological features for synergistic ischemic stroke therapy","volume":"36","author":"Tang","year":"2024","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.ijpx.2025.100404_bb0345","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S1474-4422(22)00519-1","article-title":"Thrombolysis for acute ischaemic stroke: current status and future perspectives","volume":"22","author":"Tsivgoulis","year":"2023","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100404_bb0350","doi-asserted-by":"crossref","first-page":"2000018","DOI":"10.1002\/sstr.202000018","article-title":"Drug targeting via platelet membrane-coated nanoparticles","volume":"1","author":"Wang","year":"2020","journal-title":"Small Struct."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100404_bb0355","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12951-021-01067-0","article-title":"Functionalized nanoparticles with monocyte membranes and rapamycin achieve synergistic chemoimmunotherapy for reperfusion-induced injury in ischemic stroke","volume":"19","author":"Wang","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100404_bb0360","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12951-022-01461-2","article-title":"Targeted delivery of fat extract by platelet membrane-cloaked nanocarriers for the treatment of ischemic stroke","volume":"20","author":"Wang","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"7","key":"10.1016\/j.ijpx.2025.100404_bb0365","doi-asserted-by":"crossref","first-page":"e2101349","DOI":"10.1002\/adhm.202101349","article-title":"White blood cell membrane-coated nanoparticles: recent development and medical applications","volume":"11","author":"Wang","year":"2022","journal-title":"Adv. Healthc. Mater."},{"issue":"5","key":"10.1016\/j.ijpx.2025.100404_bb0370","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1161\/STROKEAHA.117.020353","article-title":"Human neural stem cell extracellular vesicles improve recovery in a porcine model of ischemic stroke","volume":"49","author":"Webb","year":"2018","journal-title":"Stroke"},{"issue":"49","key":"10.1016\/j.ijpx.2025.100404_bb0375","doi-asserted-by":"crossref","first-page":"2006169","DOI":"10.1002\/adfm.202006169","article-title":"Engineering stem cell derived biomimetic vesicles for versatility and effective targeted delivery","volume":"30","author":"Wu","year":"2020","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100404_bb0380","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12951-022-01746-6","article-title":"Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment","volume":"20","author":"Wu","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijpx.2025.100404_bb0385","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2023.06.023","article-title":"Cell membrane-based biomimetic vehicles for effective central nervous system target delivery: Insights and challenges","volume":"360","author":"Wu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2025.100404_bb0390","doi-asserted-by":"crossref","first-page":"101800","DOI":"10.1016\/j.nantod.2023.101800","article-title":"Hybrid stem cell-derived bioresponsive vesicles for effective inflamed blood-brain barrier targeting delivery","volume":"49","author":"Wu","year":"2023","journal-title":"Nano Today"},{"issue":"14","key":"10.1016\/j.ijpx.2025.100404_bb0395","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.7150\/thno.99822","article-title":"Microenvironment-responsive nanosystems for ischemic stroke therapy","volume":"14","author":"Wu","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.ijpx.2025.100404_bb0400","doi-asserted-by":"crossref","first-page":"102444","DOI":"10.1016\/j.nantod.2024.102444","article-title":"Biomimetic nanocomplexes orchestrate post-stroke cerebral microenvironment via microglia-targeted siRNA delivery","volume":"58","author":"Wu","year":"2024","journal-title":"Nano Today"},{"issue":"4","key":"10.1016\/j.ijpx.2025.100404_bb0405","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1021\/acsnano.1c00672","article-title":"Embryonic stem cell derived small extracellular vesicles modulate regulatory T Cells to protect against ischemic stroke","volume":"15","author":"Xia","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpx.2025.100404_bb0410","doi-asserted-by":"crossref","first-page":"119491","DOI":"10.1016\/j.biomaterials.2019.119491","article-title":"Nanomaterial-based blood-brain-barrier (BBB) crossing strategies","volume":"224","author":"Xie","year":"2019","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.ijpx.2025.100404_bb0415","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1021\/acsnano.9b01798","article-title":"Sequentially site-specific delivery of thrombolytics and neuroprotectant for enhanced treatment of ischemic stroke","volume":"13","author":"Xu","year":"2019","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.ijpx.2025.100404_bb0420","doi-asserted-by":"crossref","first-page":"e1905145","DOI":"10.1002\/adma.201905145","article-title":"Engineered nanoplatelets for targeted delivery of plasminogen activators to reverse thrombus in multiple mouse thrombosis models","volume":"32","author":"Xu","year":"2020","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.ijpx.2025.100404_bb0425","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/STROKEAHA.120.032837","article-title":"Time to thrombolysis and long-term outcomes in patients with acute ischemic stroke: a nationwide study","volume":"52","author":"Yafasova","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.ijpx.2025.100404_bb0430","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.actbio.2021.12.009","article-title":"Rescuing ischemic stroke by biomimetic nanovesicles through accelerated thrombolysis and sequential ischemia-reperfusion protection","volume":"140","author":"Yu","year":"2022","journal-title":"Acta Biomater."},{"issue":"5","key":"10.1016\/j.ijpx.2025.100404_bb0435","doi-asserted-by":"crossref","first-page":"2300473","DOI":"10.1002\/sstr.202300473","article-title":"Hybrid cell membrane-coated nanoparticles for biomedical applications","volume":"5","author":"Yu","year":"2024","journal-title":"Small Struct."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100404_bb0440","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13287-019-1165-5","article-title":"Stem cells: past, present, and future","volume":"10","author":"Zakrzewski","year":"2019","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.ijpx.2025.100404_bb0445","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1021\/acsnano.3c10674","article-title":"Functionalized nanomaterials capable of crossing the blood-brain barrier","volume":"18","author":"Zha","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijpx.2025.100404_bb0450","doi-asserted-by":"crossref","first-page":"1329959","DOI":"10.3389\/fbioe.2023.1329959","article-title":"Application of stimuli-responsive nanomedicines for the treatment of ischemic stroke","volume":"11","author":"Zhan","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ijpx.2025.100404_bb0455","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jconrel.2022.02.036","article-title":"Advanced drug delivery system against ischemic stroke","volume":"344","author":"Zhang","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2025.100404_bb0460","doi-asserted-by":"crossref","first-page":"175801","DOI":"10.1016\/j.ejphar.2023.175801","article-title":"A comparative study of the neuroprotective effects of dl-3-n-butylphthalide and edaravone dexborneol on cerebral ischemic stroke rats","volume":"951","author":"Zhang","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.ijpx.2025.100404_bb0465","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1097\/JS9.0000000000001466","article-title":"Clot removAl with or without decompRessive craniectomy under ICP monitoring for supratentorial IntraCerebral Hemorrhage (CARICH): a randomized controlled trial","volume":"110","author":"Zhang","year":"2024","journal-title":"Int. J. Surg."},{"issue":"1","key":"10.1016\/j.ijpx.2025.100404_bb0470","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41392-023-01688-x","article-title":"Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijpx.2025.100404_bb0475","doi-asserted-by":"crossref","first-page":"176724","DOI":"10.1016\/j.ejphar.2024.176724","article-title":"Mangiferin alleviated poststroke cognitive impairment by modulating lipid metabolism in cerebral ischemia\/reperfusion rats","volume":"977","author":"Zhang","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijpx.2025.100404_bb0480","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2024.03.030","article-title":"Anti-inflammatory mechanisms of neutrophil membrane-coated nanoparticles without drug loading","volume":"369","author":"Zhang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2025.100404_bb0485","doi-asserted-by":"crossref","first-page":"100986","DOI":"10.1016\/j.nantod.2020.100986","article-title":"Biomimetic fibrin-targeted and H2O2-responsive nanocarriers for thrombus therapy","volume":"35","author":"Zhao","year":"2020","journal-title":"Nano Today"},{"issue":"21","key":"10.1016\/j.ijpx.2025.100404_bb0490","doi-asserted-by":"crossref","first-page":"e2311803","DOI":"10.1002\/adma.202311803","article-title":"Neutrophil membrane-camouflaged polyprodrug nanomedicine for inflammation suppression in ischemic stroke therapy","volume":"36","author":"Zhao","year":"2024","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.ijpx.2025.100404_bb0495","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/STROKEAHA.120.030859","article-title":"Routine use of tenecteplase for thrombolysis in acute ischemic stroke","volume":"52","author":"Zhong","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.ijpx.2025.100404_bb0500","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jconrel.2024.11.013","article-title":"Cell inspired delivery system equipped with natural membrane structures in applications for rescuing ischemic stroke","volume":"377","author":"Zhu","year":"2025","journal-title":"J. Control. Release"}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156725000891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156725000891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:36:05Z","timestamp":1765931765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156725000891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":100,"alternative-id":["S2590156725000891"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2025.100404","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell membrane-camouflaged nanomedicines for enhanced thrombolysis and blood-brain barrier penetration in ischemic stroke therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2025.100404","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100404"}}